U.S. Medical Countermeasure Development Since 2001: A Long Way Yet to Go-Reference-Cited by-同舟云学术

U.S. Medical Countermeasure Development Since 2001: A Long Way Yet to Go

Published:2012-03 Issue:1 Volume:10 Page:66-76
ISSN:1538-7135
Container-title:Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science
language:en
Short-container-title:Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science

Author:

Russell Philip K.¹,Gronvall Gigi Kwik¹

Affiliation:

1. Philip K. Russell, MD, Major General (ret), USA, is the former director of the Office of Research and Development Coordination, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC. Gigi Kwik Gronvall, PhD, is a Senior Associate, Center for Biosecurity of UPMC, Baltimore, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Management, Monitoring, Policy and Law,Public Health, Environmental and Occupational Health,General Medicine,Health(social science)

Link

http://www.liebertpub.com/doi/pdf/10.1089/bsp.2012.0305

Reference31 articles.

1. Shining Light on “Dark Winter”

2. ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prioritizing investments in rapid response vaccine technologies for emerging infections: A portfolio decision analysis;PLOS ONE;2021-02-11

2. Financing Vaccines for Global Health Security;SSRN Electronic Journal;2020

3. Prioritizing investments in new vaccines against epidemic infectious diseases: A multi‐criteria decision analysis;Journal of Multi-Criteria Decision Analysis;2019-05

4. Biodefense Policy Analysis—A Systems-based Approach;Health Security;2019-04

5. Confronting the threat of bioterrorism: realities, challenges, and defensive strategies;The Lancet Infectious Diseases;2019-01